COPT Defense Properties (NYSE:CDP) Given Average Recommendation of "Moderate Buy" by Analysts

Key Points

• Analyst consensus: Eight analysts rate COPT Defense Properties a consensus "Moderate Buy" (five buys, three holds) with an average 12‑month target of about $34.38.
• Q1 earnings miss but revenue beat: COPT reported Q1 EPS of $0.34 versus $0.68 expected, while revenue beat at $200.64M; management reiterated FY‑2026 EPS guidance of $2.73–2.79.
• Dividend raised: The company increased its quarterly dividend to $0.32 (annualized $1.28) for a ~4.1% yield, though the payout ratio is high at roughly 92.8%.

COPT Defense Properties (NYSE:CDP - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the eight research firms that are presently covering the stock, Marketbeat reports. Three analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 1 year target price among analysts that have covered the stock in the last year is $34.3750.

Several equities research analysts recently commented on the stock. Jefferies Financial Group boosted their price objective on shares of COPT Defense Properties from $33.00 to $34.00 and gave the stock a "buy" rating in a research report on Tuesday, January 27th. Cantor Fitzgerald reissued an "overweight" rating and issued a $37.00 target price on shares of COPT Defense Properties in a research note on Wednesday. Evercore reissued an "outperform" rating and issued a $38.00 target price on shares of COPT Defense Properties in a research note on Tuesday. Weiss Ratings raised shares of COPT Defense Properties from a "buy (b-)" rating to a "buy (b)" rating in a research note on Tuesday, April 21st. Finally, Truist Financial boosted their target price on shares of COPT Defense Properties from $31.00 to $33.00 and gave the company a "hold" rating in a research note on Tuesday, March 3rd.

Insiders Place Their Bets

In related news, Director Philip L. Hawkins sold 5,536 shares of the business's stock in a transaction dated Monday, February 23rd. The shares were sold at an average price of $32.71, for a total value of $181,082.56. Following the completion of the transaction, the director owned 15,188 shares of the company's stock, valued at approximately $496,799.48. The trade was a 26.71% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 1.66% of the company's stock.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its stake in COPT Defense Properties by 0.8% in the 4th quarter. Vanguard Group Inc. now owns 17,127,858 shares of the company's stock valued at $476,154,000 after purchasing an additional 128,583 shares during the last quarter. Alliancebernstein L.P. increased its stake in shares of COPT Defense Properties by 16.8% during the 3rd quarter. Alliancebernstein L.P. now owns 8,457,373 shares of the company's stock valued at $245,771,000 after acquiring an additional 1,215,936 shares during the last quarter. JPMorgan Chase & Co. increased its stake in shares of COPT Defense Properties by 8.3% during the 4th quarter. JPMorgan Chase & Co. now owns 3,862,294 shares of the company's stock valued at $107,372,000 after acquiring an additional 296,221 shares during the last quarter. Geode Capital Management LLC increased its stake in shares of COPT Defense Properties by 0.5% during the 4th quarter. Geode Capital Management LLC now owns 3,149,130 shares of the company's stock valued at $87,558,000 after acquiring an additional 17,049 shares during the last quarter. Finally, Channing Capital Management LLC increased its stake in shares of COPT Defense Properties by 21.0% during the 3rd quarter. Channing Capital Management LLC now owns 2,913,596 shares of the company's stock valued at $84,669,000 after acquiring an additional 506,593 shares during the last quarter.

Key Stories Impacting COPT Defense Properties

Here are the key news stories impacting COPT Defense Properties this week:

• Positive Sentiment: Cantor Fitzgerald reiterated an "overweight" rating and set a $37 price target (~19–20% upside from current levels), signaling analyst conviction that shares have upside after the pullback. Cantor Fitzgerald Reaffirms Overweight
• Positive Sentiment: Coverage pieces note COPT's growth story and rising attention around its role in the NYSE Composite index — potential index-related flows or re-weighting could support demand for the stock over time. COPT Defense Growth Story Gains Attention In NYSE Composite Index
• Positive Sentiment: Post‑quarter commentary highlighted strong FFO growth and strategic positioning that management emphasized on the earnings call — items investors view as supportive for cash flow and dividends longer term. Earnings Call Highlights
• Neutral Sentiment: Full earnings call transcript and the investor presentation were posted; these provide detail on lease performance, FFO drivers, and capital allocation for investors doing deeper due diligence. Earnings Call Transcript
• Neutral Sentiment: The company also released its Q1 earnings presentation/slides — useful for modeling and verifying the drivers behind management's guidance. Earnings Presentation
• Neutral Sentiment: A Reuters note referencing "CDP" (Italy's Cassa Depositi e Prestiti) is unrelated to COPT but can create ticker‑noise that briefly confuses retail traders; flag for traders monitoring headlines only. Reuters: Italy's CDP
• Negative Sentiment: Key negative: Q1 EPS came in at $0.34 vs. consensus ~$0.68 (and vs. $0.65 a year earlier), a sizable miss that likely drove the immediate price weakness despite a revenue beat; management issued FY‑2026 EPS guidance of $2.73–2.79, which roughly lines up with analyst expectations but didn't prevent the selloff after the EPS miss. Q1 Earnings Snapshot

COPT Defense Properties Price Performance

COPT Defense Properties stock opened at $30.94 on Thursday. COPT Defense Properties has a 52 week low of $25.21 and a 52 week high of $33.29. The company has a quick ratio of 3.95, a current ratio of 3.95 and a debt-to-equity ratio of 1.77. The firm's 50-day simple moving average is $31.83 and its 200 day simple moving average is $30.30. The firm has a market capitalization of $3.51 billion, a PE ratio of 22.42 and a beta of 0.86.

COPT Defense Properties (NYSE:CDP - Get Free Report) last released its quarterly earnings data on Monday, April 27th. The company reported $0.34 EPS for the quarter, missing the consensus estimate of $0.68 by ($0.34). COPT Defense Properties had a return on equity of 10.05% and a net margin of 20.10%.The business had revenue of $200.64 million during the quarter, compared to analysts' expectations of $185.41 million. During the same quarter in the prior year, the firm earned $0.65 earnings per share. COPT Defense Properties's quarterly revenue was up 6.8% on a year-over-year basis. COPT Defense Properties has set its FY 2026 guidance at 2.730-2.790 EPS and its Q2 2026 guidance at 0.680-0.700 EPS. On average, equities research analysts predict that COPT Defense Properties will post 2.78 EPS for the current fiscal year.

COPT Defense Properties Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, April 15th. Investors of record on Tuesday, March 31st were paid a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 4.1%. The ex-dividend date of this dividend was Tuesday, March 31st. This is a positive change from COPT Defense Properties's previous quarterly dividend of $0.31. COPT Defense Properties's dividend payout ratio is presently 92.75%.

COPT Defense Properties Company Profile

COPT Defense Properties NYSE: CDP is a real estate investment trust organized to own, lease and manage healthcare and life science facilities serving the United States federal government, with a particular focus on Department of Defense and Veterans Affairs tenants. The company was formed in 2016 through a spin-off from Corporate Office Properties Trust, enabling it to concentrate exclusively on medical office buildings and specialized research facilities situated on or near military and federal research campuses.

The company's portfolio comprises purpose-built, Class A medical office and outpatient specialty clinics, as well as life science laboratories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.